FIC: Vulnerable Investor Protection Bill Moves in House

By:  Katrina Callaway, FIC General Counsel The House Insurance and Banking Subcommittee adopted a committee substitute for the vulnerable investor bill during its meeting on March 13, 2019.  The committee substitute replaces the originally filed version of the bill. Some in the life insurance community are following this bill closely due to the employee training…

FIC: Health Shared Savings Bill Moving In House

By:  Katrina Callaway, FIC General Counsel HB 1113 creates a voluntary health shared savings incentive program to allow health insurers and HMOs to provide cash or other incentives to insureds when they obtain shoppable health care services on the insurer’s or HMO’s shared savings incentive list.  The shoppable services are those that are non-emergency, including…

FIC: Pharmacists Allowed To Treat Under Approved Bill

By:  Katrina Callaway, FIC General Counsel HB 833 allows consultant pharmacists to provide specified health care services under a collaborative practice agreement with an MD, DO, podiatrist, or dentist.  Collaborative practice agreements are voluntary.   Pharmacists with collaborative practice agreements with health care providers can provide medication management, order and evaluate tests, conduct patient assessments…

FIC: Auto Insurance Omnibus Bill Starts Moving

By:  Katrina Callaway, FIC General Counsel HB 765 is a compilation of auto insurance issues, namely auto insurance verification system, named driver exclusion, prepayment of premium for auto insurance, and salvage motor vehicles. The bill passed its first House committee on March 12, 2019.  It was amended with a strike all amendment that removed some…

FIC: Life Insurance Genetic Testing Prohibition Approved

By:  Katrina Callaway, FIC General Counsel SB 258 prohibits life insurers, long-term care insurers, and disability insurers from cancelling, limiting, or denying coverage or establishing different premiums based on the genetic information.  The bill also prohibits these insurers from using genetic information or requiring genetic testing for any insurance purpose unless there is a diagnosis…